Search Results - "Sengeløv, H"

Control of exocytosis in early neutrophil activation by Sengelov, H, Kjeldsen, L, Borregaard, N

“…Exocytosis of human neutrophil secretory vesicles, gelatinase granules, specific granules, and azurophil granules was measured during modulation of the…”
Get full text

P537: SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN ADULTS IN DENMARK FROM 2000 TO 2020: A POPULATION‐BASED COHORT STUDY by Gjærde, L. K., Jakobsen, L. H., Juhl‐Christensen, C., Olesen, G., Petruskevicius, I., Severinsen, M. T., Marcher, C. W., Theilgaard‐Mönch, K., Andersen, N. S., Friis, L. S., Kornblit, B., Petersen, S. L., Schjødt, I., Sengeløv, H.

Get full text

The Role of Gamma Delta T Cells in Haematopoietic Stem Cell Transplantation by Minculescu, L., Sengeløv, H.

“…Although haematopoietic stem cell transplantation (HSCT) is a potential curative treatment for haematological malignancies, it is still a procedure associated…”
Get full text

Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study by Østgård, L S G, Nørgaard, J M, Sengeløv, H, Severinsen, M, Friis, L S, Marcher, C W, Dufva, I H, Nørgaard, M

“…As the world population ages, the comorbidity burden in acute myeloid leukemia (AML) patients increases. Evidence on how to integrate comorbidity measures into…”
Get full text

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT by Cahu, X, Labopin, M, Giebel, S, Aljurf, M, Kyrcz-Krzemien, S, Socié, G, Eder, M, Bonifazi, F, Bunjes, D, Vigouroux, S, Michallet, M, Stelljes, M, Zuckerman, T, Finke, J, Passweg, J, Yakoub-Agha, I, Niederwieser, D, Sucak, G, Sengeløv, H, Polge, E, Nagler, A, Esteve, J, Mohty, M

“…Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a therapeutic option for adult patients with T-cell ALL (T-ALL). Meanwhile, few allo-SCT data…”
Get full text

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia by Ruggeri, A, Labopin, M, Sanz, G, Piemontese, S, Arcese, W, Bacigalupo, A, Blaise, D, Bosi, A, Huang, H, Karakasis, D, Koc, Y, Michallet, M, Picardi, A, Sanz, J, Santarone, S, Sengelov, H, Sierra, J, Vincent, L, Volt, F, Nagler, A, Gluckman, E, Ciceri, F, Rocha, V, Mohty, M

“…Outcomes after unmanipulated haploidentical stem cell transplantation (Haplo) and after unrelated cord blood transplantation (UCBT) are encouraging and have…”
Get full text

Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning by Askaa, B, Fischer-Nielsen, A, Vindeløv, L, Haastrup, E K, Sengeløv, H

Get full text

Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors by Mortensen, B K, Jacobsen, N, Heilmann, C, Sengeløv, H

Get full text

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors by PETERSEN, S. L, RYDER, L. P, BJÖRK, P, MADSEN, H. O, HEILMANN, C, JACOBSEN, N, SENGELØV, H, VINDELØV, L. L

“…This retrospective study compares the reconstitution of T, B and NK cells in three groups of patients transplanted for haematological malignancies with grafts…”
Get full text

Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient by Oosterhof, L, Christensen, C B, Sengeløv, H

Get full text

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia by Craddock, Charles, Labopin, Myriam, Robin, Marie, Finke, Juergen, Chevallier, Patrice, Yakoub-Agha, Ibrahim, Bourhis, Jean Henri, Sengelov, Henrik, Blaise, Didier, Luft, Thomas, Hallek, Michael, Kröger, Nicolaus, Nagler, Arnon, Mohty, Mohamad

“…Disease relapse is the most common cause of treatment failure after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic…”
Get full text

Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation by Weischendorff, S, Kielsen, K, Sengeløv, H, Jordan, K, Nielsen, C H, Pedersen, A E, Ryder, L P, Juul, A, Müller, K G

“…Allogeneic myeloablative haematopoietic stem cell transplantation (HSCT) is challenged by severe adverse events, as cytotoxic effects of the conditioning may…”
Get full text

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis by Bacigalupo, Andrea, Socié, Gerard, Hamladji, Rose Marie, Aljurf, Mahmoud, Maschan, Alexei, Kyrcz-Krzemien, Slawomira, Cybicka, Alicja, Sengelov, Henrik, Unal, Ali, Beelen, Dietrich, Locasciulli, Anna, Dufour, Carlo, Passweg, Jakob R, Oneto, Rosi, Signori, Alessio, Marsh, Judith C W

“…We have analyzed 1448 patients with acquired aplastic anemia grafted between 2005 and 2009, and compared outcome of identical sibling (n=940) versus unrelated…”
Get full text

Subcellular localization and dynamics of Mac-1 (αmβ2) in human neutrophils by SENGELØV, H, KJELDSEN, L, DIAMOND, M. S, SPRINGER, T. A, BORREGAARD, N

“…The subcellular localization of Mac-1 was determined in resting and stimulated human neutrophils after disruption by nitrogen cavitation and fractionation on…”
Get full text

The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection by Wareham, Neval E., Lundgren, J. D., Da Cunha-Bang, C., Gustafsson, F., Iversen, M., Johannesen, H. H., Kjær, A., Rasmussen, A., Sengeløv, H., Sørensen, S. S., Fischer, B. M.

“…Purpose Solid organ transplant (SOT) recipients are at high risk of developing infections and malignancies. 18 F-FDG PET/CT may enable timely detection of…”
Get full text

T cell Reconstitution in Allogeneic Haematopoietic Stem Cell Transplantation: Prognostic Significance of Plasma Interleukin‐7 by Kielsen, K., Jordan, K. K., Uhlving, H. H., Pontoppidan, P. L., Shamim, Z., Ifversen, M., Heilmann, C., Nielsen, C. H., Sengeløv, H., Ryder, L. P., Müller, K. G.

“…Infections and acute graft‐versus‐host disease (aGVHD) are major causes of treatment‐related mortality and morbidity following allogeneic haematopoietic stem…”
Get full text

Pretransplant C‐reactive Protein as A Prognostic Marker in Allogeneic Stem Cell Transplantation by Jordan, K. K. I., Christensen, I. J., Heilmann, C., Sengeløv, H., Müller, K. G.

“…We evaluated the prognostic role of baseline levels of C‐reactive protein (CRP) as well as CRP levels during conditioning in patients undergoing myeloablative…”
Get full text

Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study by Østgard, L S G, Nørgaard, J M, Sengeløv, H, Holm, M S, Jensen, M K, Kallenbach, M, Marcher, C W, Nielsen, O J, Nørgaard, M

Get full text

Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable? by Ekenberg, C., Lodding, I. P., Wareham, N. E., Sørensen, S. S., Sengeløv, H., Gustafsson, F., Rasmussen, A., Perch, M., Lundgren, J. D., Helleberg, M.

“…Transplant recipients are at high risk of cytomegalovirus (CMV) infection. Mechanisms explaining the variation in risk of infections are far from fully…”
Get full text

Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation by Jordan, K, Christensen, I J, Jørgensen, M H, Heilmann, C, Sengeløv, H, Müller, K G

Get full text